NDC 62135-054 – Doxazosin mesylate
Doxazosin Mesylate 8 mg/1 · Tablet · Oral
Product NDC62135-054
Product details
- Brand name
- Doxazosin mesylate
- Generic name
- Doxazosin mesylate
- Labeler
- Chartwell RX, LLC
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA075646
- Marketed since
- October 18, 2000
- Listing expires
- December 31, 2026
- Pharmacologic class
- alpha-Adrenergic Blocker
Active ingredients
- Doxazosin Mesylate 8 mg/1
Uses, dosage, side effects and warnings for Doxazosin mesylate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62135-054-90 | 90 TABLET in 1 BOTTLE (62135-054-90) | Jun 6, 2023 |
Other Doxazosin mesylate products
- 71610-965 Doxazosin Mesylate 4 mg/1 · Tablet · Aphena Pharma Solutions - Tennessee, LLC
- 62135-051 Doxazosin Mesylate 1 mg/1 · Tablet · Chartwell RX, LLC
- 62135-052 Doxazosin Mesylate 2 mg/1 · Tablet · Chartwell RX, LLC
- 62135-053 Doxazosin Mesylate 4 mg/1 · Tablet · Chartwell RX, LLC
- 59762-1388 Doxazosin Mesylate 1 mg/1 · Tablet · Mylan Pharmaceuticals Inc.
- 59762-1389 Doxazosin Mesylate 2 mg/1 · Tablet · Mylan Pharmaceuticals Inc.
- 59762-1390 Doxazosin Mesylate 4 mg/1 · Tablet · Mylan Pharmaceuticals Inc.
- 59762-1391 Doxazosin Mesylate 8 mg/1 · Tablet · Mylan Pharmaceuticals Inc.
- 53747-352 Doxazosin Mesylate 2 mg/1 · Tablet · Unichem Laboratories Limited, India
- 29300-351 Doxazosin Mesylate 1 mg/1 · Tablet · Unichem Pharmaceuticals (USA), Inc.
- 29300-352 Doxazosin Mesylate 2 mg/1 · Tablet · Unichem Pharmaceuticals (USA), Inc.
- 29300-353 Doxazosin Mesylate 4 mg/1 · Tablet · Unichem Pharmaceuticals (USA), Inc.